ArticleBMC neurology2026
Adult-onset neuronal intranuclear inclusion disease initially presenting with prominent gastrointestinal symptoms: a case report.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundNeuronal intranuclear inclusion disease (NIID) is a rare and progressive neurodegenerative disorder, distinguished by extreme clinical heterogeneity that frequently results in diagnostic delays. While gastrointestinal symptoms are common in NIID, the prolonged gastrointestinal-dominant prodrome—lasting years before neurological signs emerge—remains under-recognized in adult-onset cases. CASE PRESENTATION: We report a 59-year-old female evaluated in the gastroenterology department for a four-year history of recurrent vomiting and abdominal pain. Comprehensive investigations, including endoscopy, abdominal CT scans, and laboratory studies, excluded significant structural or inflammatory pathology. She was admitted on March 30, 2024, for another episode of abdominal pain and vomiting. Over the disease course, her symptoms extended beyond the gastrointestinal tract to include cognitive decline, urinary retention, and two episodes of impaired consciousness. On April 2, 2024, she acutely developed stroke-like manifestations—somnolence, loss of speech, and left-sided hemiparesis—requiring urgent transfer to neurology. Brain MRI demonstrated cerebral atrophy, extensive confluent white matter hyperintensities with frontoparietal predominance, and characteristic linear DWI hyperintensities along the corticomedullary junction. Genetic testing ultimately confirmed neuronal intranuclear inclusion disease (NIID).
conclusionThis case underscores the fact that NIID may present with prominent gastrointestinal symptoms in its early stages. Therefore, NIID should be considered in the differential diagnosis for patients with chronic unexplained gastrointestinal complaints, particularly those with concurrent autonomic or subtle neurological dysfunction. A timely diagnosis requires comprehensive neurological assessments, characteristic MRI findings, and definitive genetic testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.